CVSI - CV Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.8600
+0.0200 (+0.41%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close4.8400
Open4.8650
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range4.8100 - 5.0300
52 Week Range1.0600 - 9.2000
Volume523,812
Avg. Volume1,064,428
Market Cap486.909M
Beta (3Y Monthly)-0.88
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateJul 30, 2019 - Aug 5, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • GlobeNewswire5 days ago

    CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD

    CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, is pleased to announced that its industry-dominating PlusCBD Oil™ products were used in the first study to date examining the clinical benefit of CBD for the treatment of Post-Traumatic Stress Disorder (PTSD). The study, published in The Journal of Alternative and Complementary Medicine in April 2019, examined the effect of oral CBD administration on symptoms of PTSD in a series of 11 adult patients at an outpatient psychiatry clinic.

  • Thomson Reuters StreetEvents9 days ago

    Edited Transcript of CVSI earnings conference call or presentation 8-May-19 8:30pm GMT

    Q1 2019 CV Sciences Inc Earnings Call

  • GlobeNewswire11 days ago

    CV Sciences, Inc. Reports First Quarter 2019 Financial Results

    Record quarterly revenue Increased retail distribution by over 1,000 stores LAS VEGAS, May 08, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”).

  • GlobeNewswire12 days ago

    CV Sciences, Inc. to Present at Upcoming Investor Conferences

    LAS VEGAS, May 07, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products.

  • CV Sciences, Inc. (CVSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks18 days ago

    CV Sciences, Inc. (CVSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    CV Sciences, Inc. (CVSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • ACCESSWIRE19 days ago

    There is No Slowdown Ahead for CBD Growth in 2019

    Not only has it transformed multi-billion-dollar industries including alcohol, health and wellness, cigarettes, and the retail industry, it's impacting food, too. Better, the U.S. FDA could provide a substantial boost to cannabis stocks in weeks. Lifestyle Delivery Systems Inc. (LDS)(LDSYF) just announced that its flagship product, Cannastrips will be presented at the Hall of Flowers (HoF) event.

  • GlobeNewswire19 days ago

    CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2019

    CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its first quarter 2019 ended March 31, 2019, after the stock market closes on Wednesday, May 8, 2019. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day. The webcast of the conference call will be available on the Investor Relations section of the Company's website at https://ir.cvsciences.com/news-events and at http://public.viavid.com/index.php?id=134448.

  • ACCESSWIRE26 days ago

    With Strong Demand, More Top Retailers are Just Beginning to Sell CBD Products

    Neiman Marcus is pushing ahead with CBD sales at some of its stores and online. Simon Property Group is partnering with Green Growth Brands to open 108 stores in its malls just in 2019. CVS will carry a line of CBD products in eight states, including California, Illinois, Colorado, and Alabama.

  • Benzingalast month

    Canadian Investors Can Light Up A New Cannabis ETF Focused On US Companies

    Horizons is the company behind the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ)(OTC: HMLSF), which is one of the world's largest cannabis ETFs. “HMUS will be the first ETF in the world that is solely focused on providing exposure to companies with significant business activities in, or significant exposure to, the United States marijuana or hemp industries,” according to a statement.

  • GlobeNewswirelast month

    CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor

    LAS VEGAS, April 15, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products,.

  • ACCESSWIRElast month

    Three Companies Giving Investor the Biggest Exposure to CBD Growth

    HOUSTON, TX / ACCESSWIRE / April 12, 2019 / According to the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022 - a compound growth rate of 147%. Some of those companies include Lifestyle Delivery Systems Inc. (CSE: LDS)(OTC: LDSYF), Charlotte's Web Holdings Inc. (CN: CWEB)(OTC: CWBHF), and CV Sciences Inc. (NASDAQ: CVSI). Lifestyle Delivery Systems Inc.'s (LDS)(LDSYF) wholly owned subsidiary, CSPA Group just entered into an agreement to provide Mbioteq with a minimum of 120 liters of 85% THC raw distillate oil per month.

  • GlobeNewswirelast month

    CV Sciences, Inc. Announces Distribution Expansion Into Food, Drug and Mass Channels

    LAS VEGAS, April 10, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products, is.

  • ACCESSWIRE2 months ago

    The Up-And-Coming Cannabis Producer That's About To Double Their Production Potential

    The illicit cannabis industry is estimated at $50 billion yearly, much of which will move out of the shadows and become a legal market in the coming years. One research firm estimates the legal trade could be worth $21 billion by 2021. Item 9 Labs (INLB) could be one of these as they finish a major expansion project on their Arizona cannabis cultivation and production facility, doubling capacity.

  • 3 Best Marijuana Stocks in March: Are They Buys Now?
    Motley Fool2 months ago

    3 Best Marijuana Stocks in March: Are They Buys Now?

    Spring forward in March? These three marijuana stocks did a lot more than that.

  • ACCESSWIRE2 months ago

    Cannabis Has an Energy Problem, CLSK Has the Solution

    HENDERSON, NV / ACCESSWIRE / March 26, 2019 / The electricity consumption of cannabis grow houses is staggering when compared to business and residential use. In 2015, the average electricity consumption ...

  • ACCESSWIRE2 months ago

    These Four Marijuana Stocks Could Test March Highs on Monday

    Leafbuyer Technologies Inc (OTC:LBUY), CV Sciences Inc (CVSI), MedMen Enterprises Inc (MMNFF) (MMEN.CN), and Terra Tech Corp (TRTC) represent 4 marijuana stocks leading the pack on Monday. More than ever, consumers depend on online resources to research the products they are interested in buying and, prior to Leafbuyer's platform, no reliable source existed for information on cannabis and related products. Leafbuyer Technologies Inc (OTC:LBUY) earlier this month announced that the total number of Greenlight platform users has reached nearly 80,000.

  • GlobeNewswire2 months ago

    CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer

    LAS VEGAS, March 21, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products.

  • ACCESSWIRE2 months ago

    These Four Marijuana Stocks Could Spark Activity On Thursday

    Leafbuyer Technologies Inc (LBUY), CV Sciences Inc (CVSI), Trulieve Cannabis Corp (OTC PINK: TCNNF) (TRUL.CN), and GW Pharmaceuticals plc (NASDAQ:GWPH) represent 4 marijuana stocks leading the industry on Thursday. Nowadays, consumers depend on online resources to research the products they are interested in buying and, prior to Leafbuyer's platform, there hadn't been a reliable source for information on cannabis and related products. In recognition of this growing trend to do one's homework, Leafbuyer has become the authority on cannabis-related information.

  • Benzinga2 months ago

    CV Sciences Skewing Successfully Thanks To CBD Sales

    Earlier this month, CV Sciences Inc (OTCMKTS: CVSI) released their financial results for the fiscal year ending on Dec. 31, 2018, posting record growth in both revenue and retail distribution. Indeed, CV Sciences finished out the fiscal year with a particularly strong fourth quarter. One of CV Sciences most popular product lines is PlusCBD Gold, which contains high concentrations of CBD instead of a mixture of CBD, CBDA, and other hemp-derived cannabinoids.

  • ACCESSWIRE2 months ago

    Four Marijuana Stocks Surpassing Investor Expectations

    The cannabis industry has been extremely fortunate in the U.S. to see a massive amount of support across the nation. Nabis Holdings (INNPF) (NAB), Newstrike Brands Ltd (OTC PINK: NWKRF), CannTrust Holdings Inc (CTST) (TRST.TO), and CV Sciences Inc (CVSI) are 4 pot stocks that could test March highs. Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.

  • ACCESSWIRE2 months ago

    Smaller Pot Stocks You Should Know

    HENDERSON, NV / ACCESSWIRE / March 15, 2019 / The biggest marijuana stocks get the most attention. But the global marijuana market is worth $150 billion annually and that suggests there's plenty of room ...

  • OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
    PR Newswire2 months ago

    OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

    OTCQX and OTCQB Companies Featured at 2019 ROTH Conference NEW YORK , March 13, 2019 /PRNewswire/ --  OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, ...

  • GlobeNewswire2 months ago

    CV Sciences, Inc. Reports Fiscal Year-End 2018 Financial Results

    Record full year revenue LAS VEGAS, March 12, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (“CV Sciences” or the “Company”) announced today its financial results for the year ended.

  • ACCESSWIRE2 months ago

    Watch These Four Marijuana Stocks Test Their Limits On Friday

    CORAL GABLES, FL / ACCESSWIRE / March 8, 2019 / Though the marijuana stock market and its accompanying industry are still very much in their infancy, cannabis companies have managed to attract significant investor attention during the course of the first few months of 2019. The primary focus of legislators now is convincing the federal government to remove marijuana's scheduled narcotic status, so that companies can access the domestic market in its entirety and offer consumers high-quality cannabis products. The future of the cannabis industry will be bright so long as public opinion surrounding marijuana legislation remains supportive and lawmakers continue to advocate for legalization.

  • Benzinga3 months ago

    US Hemp Authority Issues First 13 Certification Seals

    The U.S. Hemp Authority, an industry group responsible for the U.S. Hemp Authority Certification Program, announced the first awards of its Certification Seal Friday to companies meeting standards for ...